<DOC>
	<DOC>NCT00446758</DOC>
	<brief_summary>To examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression, and improves growth.</brief_summary>
	<brief_title>Trial of Zinc and HIV Progression in Children</brief_title>
	<detailed_description>The purpose of this study is to examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression, and improves growth.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>HIV Infected Children under 60 months of age presenting at HIV treatment clinics in Dar es Salaam, Tanzania Eligible for ART: CD4 cell counts &lt; 20% or above pediatric clinical stage of HIV disease 3 according to WHO staging system. Severe acute malnutrition; Major congenital malformations</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>60 Months</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Zinc</keyword>
	<keyword>HIV</keyword>
	<keyword>Infants</keyword>
	<keyword>Children</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Child health outcomes</keyword>
	<keyword>treatment naive</keyword>
	<keyword>treatment experienced</keyword>
</DOC>